APLT שיעור רווח גולמי Applied Therapeutics

סמלים רשמיים של חברת Applied Therapeutics, Inc. (APLT)

Applied Therapeutics develops drugs for the treatment of rare pathologies, relying on the high cost of orphan drugs to cover R&D expenses. The company implements "green chemistry" methods and utilizes production outsourcing to reduce its environmental footprint. The change in gross profit margin demonstrates the operational resilience of the business, with the indicator value standing at 59.60.

Applied Therapeutics, Inc. (APLT): שולי רווח גולמי מ-04.07.2022 עד 16.02.2026

פילוחים אנליטיים ודוחות נתונים של חברת Applied Therapeutics (APLT)

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח בסיסי של החברה:Applied Therapeutics Inc. APLT
מוצר המיוצר על ידי Applied Therapeutics Inc.

Applied Therapeutics focuses on bringing innovative drugs for the treatment of rare metabolic disorders to market, creating long-term value through regulatory approvals. This metric measures the share of profit after deducting direct production costs, allowing the investor to assess operational efficiency and the pricing power of products via the adjusted gross margin.